The fastest-growing market segment for biologics
● Diabetic foot ulcers and chronic wounds
● Pressure ulcers and venous leg ulcers
● Complex wound environments requiring biological coverage
● Post-surgical wound management
● Wound care centers and hospital-based programs
Market Leadership: Wound care represents 70% of the current biologics market with explosive growth projected through 2027.